Decreased total liver lipid content in the groups treated with BC might agree with a previous report of a protective effect of BC (mainly 9-cis, from algal origin) against the development of hepatic steatosis in LDL receptor knockout mice fed an HFD [52]. The gene discussed is LDLR; the disease is Hepatic steatosis.